GB virus C (GBV-C) hepatitis G virus (HGV): Towards the design of synthetic peptides-based biosensors for immunodiagnosis of GBV-C/HGV infection

被引:16
|
作者
Rojo, N
Ercilla, G
Haro, I
机构
[1] CSIC, IIQAB, Dept Peptide & Prot Chem, Barcelona 08034, Spain
[2] Clin Hosp, ICII IDIBAPS, Dept Immunol, Barcelona 08036, Spain
关键词
D O I
10.2174/1389203033487135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present Study, new putative epitopes located in structural (E2) and non-structural (NS3) proteins of GBV-C/HGV were identified by computer-aided prediction of antigenicity and synthesized in solid-phase, following all Fmoc/tBut strategy, for their use in immunoassays. The corresponding synthetic peptides were used as antigens in ELISA assays and in real-time biospecific interaction measurements. This last approach allowed direct detection of GBV-C/HGV-specific antibodies in human sera. Good correlations were obtained between the biospecific interaction analysis and the ELISA. To verify the performance of these new assays in comparison to the existing recombinant E2 protein commercial test, antibodies to synthetic peptides were searched for in different panels of serum samples. The main conclusion of this work is the usefulness of E2 peptides in the detection of antibodies. Moreover, the NS3 peptide could be exploited to improve the sensitivity of the currently available test. Our results offer a new approach to develop new diagnostic peptide based biosensors for scrodiagnosis of GBV-C/HGV infection.
引用
收藏
页码:291 / 298
页数:8
相关论文
共 50 条
  • [41] GBV-C/HGV infection in renal dialysis and transplant patients
    Szabo, A
    Viazov, S
    Heemann, U
    Kribben, A
    Philipp, T
    Roggendorf, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (11) : 2380 - 2384
  • [42] No correlation between GBV-C/HGV infection and hepatocellular carcinoma
    Tanaka, Y
    Mizokami, M
    Kato, T
    Mukaide, M
    Orito, E
    Ohba, K
    Nakano, T
    Kondo, Y
    Ueda, R
    HEPATOLOGY, 1997, 26 (04) : 1933 - 1933
  • [43] GB virus C hepatitis G virus (GBV-C/HGV) infection in Chiang Mai, Thailand, and identification of variants on the basis of 5′-untranslated region sequences
    Katayama, Y
    Apichartpiyakul, C
    Handajani, R
    Ishido, S
    Hotta, H
    ARCHIVES OF VIROLOGY, 1997, 142 (12) : 2433 - 2445
  • [44] A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany
    Yan, J
    Dennin, RH
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (06) : 833 - 841
  • [45] Involvement of GBV-C/HGV in liver diseases in Japan
    Iino, S
    Sato, S
    Kumada, H
    Toda, G
    Ishii, H
    Miyake, K
    Hino, K
    Ichida, T
    Akahane, Y
    Kiyosawa, K
    Kobayashi, K
    Hayashi, N
    Kuroki, T
    Tsuji, T
    Sata, M
    Sakai, T
    Yano, M
    HEPATOLOGY RESEARCH, 1999, 13 (02) : 153 - 159
  • [46] A high frequency of GBV-C/HGV coinfection in hepatitis C patients in Germany
    Reinhard H. Dennin
    World Journal of Gastroenterology, 2000, 6 (06) : 833 - 841
  • [47] Synthetic Peptides of Hepatitis G Virus (GBV-C/HGV) in the Selection of Putative Peptide Inhibitors of the HIV-1 Fusion Peptide
    Herrera, Elena
    Gomara, Maria J.
    Mazzini, Stefania
    Ragg, Enzio
    Haro, Isabel
    JOURNAL OF PHYSICAL CHEMISTRY B, 2009, 113 (20): : 7383 - 7391
  • [48] GB Virus C (GBV-C/HGV) and E2 Antibodies in Children Preliver and Postliver Transplant
    Orit Elkayam
    Howayda M Hassoba
    Linda D Ferrell
    Richard Garcia-Kennedy
    Robert G Gish
    Teresa L Wright
    Tom Laffler
    Dena Traylor
    Geffrey Hunt
    Philip Rosenthal
    Pediatric Research, 1999, 45 : 795 - 798
  • [49] Interaction of synthetic peptides corresponding to hepatitis G virus (HGV/GBV-C) E2 structural protein with phospholipid vesicles
    Larios, C
    Christiaens, B
    Gómara, MJ
    Alsina, MA
    Haro, I
    FEBS JOURNAL, 2005, 272 (10) : 2456 - 2466
  • [50] GBV-C/HGV:: A new virus within the Flaviviridae and its clinical implications
    Hadlock, KG
    Foung, SKH
    TRANSFUSION MEDICINE REVIEWS, 1998, 12 (02) : 94 - 108